US equities
|
MU
$909.84
▲+0.55%
NVDA
$216.84
▼-0.12%
SPCX
$147.40
▼-0.38%
TSLA
$373.79
▲+1.56%
META
$690.15
▼-2.17%
SNDK
$1,381.78
▲+0.78%
INTC
$92.60
▲+0.61%
AMZN
$263.13
▲+0.26%
MU
$909.84
▲+0.55%
NVDA
$216.84
▼-0.12%
SPCX
$147.40
▼-0.38%
TSLA
$373.79
▲+1.56%
META
$690.15
▼-2.17%
SNDK
$1,381.78
▲+0.78%
INTC
$92.60
▲+0.61%
AMZN
$263.13
▲+0.26%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about CaaMTech Inc/
Recent news which mentions CaaMTech Inc/
FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment
November 14, 2024
Tickers
CMPS
NEWS
Tags
FDA
Lykos Therapeutics
Cannabis
From
Benzinga
Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments
November 12, 2024
Tickers
NEWS
Tags
Psychedelics Research
Psilocybin
Psychedelic Assisted Therapies
From
Benzinga
Exclusive: CaaMTech And Alexander Shulgin Research Institute To Follow Study On Shulgin's Compounds
July 06, 2022
Tags
Psychedelics
Cannabis
News
From
Benzinga